Virtual Teams: What We Know, What We Don't Know

Do We Know What We Do not Know? A Response to Celine Bonnet

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

Travel Diarrhea in Childhood “First Part; what do we know?”

Teaching and Learning about Virtual Collaboration: What We Know and Need to Know

Virtual collaboration is an essential skill in today’s organizations, but where and how do people learn it? What do we know about teaching and learning with respect to virtual collaboration? We examined this question from multiple perspectives: (1) best practices in virtual teams, in order to provide the content of what might be taught about virtual collaboration; (2) best practices in teaching...

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...